Cargando…
Identification of a novel platelet antagonist that binds to CLEC-2 and suppresses podoplanin-induced platelet aggregation and cancer metastasis
Podoplanin (PDPN) enhances tumor metastases by eliciting tumor cell-induced platelet aggregation (TCIPA) through activation of platelet C-type lectin-like receptor 2 (CLEC-2). A novel and non-cytotoxic 5-nitrobenzoate compound 2CP was synthesized that specifically inhibited the PDPN/CLEC-2 interacti...
Autores principales: | Chang, Yao-Wen, Hsieh, Pei-Wen, Chang, Yu-Tsui, Lu, Meng-Hong, Huang, Tur-Fu, Chong, Kowit-Yu, Liao, Hsiang-Ruei, Cheng, Ju-Chien, Tseng, Ching-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4767466/ https://www.ncbi.nlm.nih.gov/pubmed/26528756 |
Ejemplares similares
-
Platelets Promote Tumor Growth and Metastasis via Direct Interaction between Aggrus/Podoplanin and CLEC-2
por: Takagi, Satoshi, et al.
Publicado: (2013) -
Podoplanin-expressing inflammatory macrophages activate murine platelets via CLEC-2
por: Kerrigan, A M, et al.
Publicado: (2012) -
Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2
por: Herzog, Brett H., et al.
Publicado: (2013) -
Platelet CLEC2-Podoplanin Axis as a Promising Target for Oral Cancer Treatment
por: Hwang, Byeong-Oh, et al.
Publicado: (2021) -
Platelet Adhesion to Podoplanin Under Flow is Mediated by the Receptor CLEC-2 and Stabilised by Src/Syk-Dependent Platelet Signalling
por: Navarro-Núñez, Leyre, et al.
Publicado: (2015)